These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1181 related articles for article (PubMed ID: 19505427)

  • 1. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
    Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
    Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
    Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
    Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
    Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
    Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
    Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
    Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
    Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
    Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
    Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.
    Sakuraba A; Sato T; Kamada N; Kitazume M; Sugita A; Hibi T
    Gastroenterology; 2009 Nov; 137(5):1736-45. PubMed ID: 19632232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation.
    Sugimoto K; Ogawa A; Shimomura Y; Nagahama K; Mizoguchi A; Bhan AK
    Gastroenterology; 2007 Jul; 133(1):124-36. PubMed ID: 17631137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.